{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:06:57Z","timestamp":1791166017416,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["P014534"],"award-info":[{"award-number":["P014534"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000395","name":"Royal College of Physicians","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejps.2020.105643","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:56:30Z","timestamp":1605182190000},"page":"105643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study"],"prefix":"10.1016","volume":"158","author":[{"given":"Jaya Madhura","family":"Parasuraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kloprogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Frank","family":"Standing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-7280","authenticated-orcid":false,"given":"Mahableshwar","family":"Albur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Heep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2020.105643_bib0006","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1542\/peds.2007-0423","article-title":"(NICHD Research Network). Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion","volume":"121","author":"Adams-Chapman","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejps.2020.105643_bib0023","unstructured":"Assay verification-Indiko Plus assays Vancomycin (2017). Department of Medical Microbiology. North Bristol NHS Trust.Version 1.0.Available on request as internal document of North Bristol NHS trust."},{"issue":"12","key":"10.1016\/j.ejps.2020.105643_bib0016","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","article-title":"Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review","volume":"56","author":"Beach","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ejps.2020.105643_bib0012","unstructured":"British National Formulary for Children. Vancomycin: Monitoring Requirements. 2018. https:\/\/bnfc.nice.org.uk\/drug\/vancomycin.html#monitoringRequirements."},{"issue":"sup1","key":"10.1016\/j.ejps.2020.105643_bib0003","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3109\/14767058.2013.796167","article-title":"Treatment of neonatal progressive ventricular dilatation: a single-centre experience","volume":"28","author":"Brouwer","year":"2015","journal-title":"J Matern Neonatal Med"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0019","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1148\/radiol.11110334","article-title":"New Reference Values for the Neonatal Cerebral Ventricles","volume":"262","author":"Brouwer","year":"2012","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/02688690042834","article-title":"The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis","volume":"14","author":"Brown","year":"2000","journal-title":"Br J Neurosurg"},{"issue":"3","key":"10.1016\/j.ejps.2020.105643_bib0033","first-page":"801","article-title":"Impact of vancomycin protein binding on target attainment in critically ill children: back to the drawing board","volume":"72","author":"De Cock","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.ejps.2020.105643_bib0011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/00003088-200443070-00001","article-title":"Vancomycin:Pharmacokinetics and administration regimens in neonates","volume":"43","author":"de Hoog","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0021","first-page":"24","article-title":"European Committee on Antimicrobial Susceptibility Testing","volume":"Version 7","year":"2017","journal-title":"Breakpoint tables for interpretation of MICs and zone diameters"},{"issue":"4","key":"10.1016\/j.ejps.2020.105643_bib0025","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bcp.13160","article-title":"Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful","volume":"83","author":"Germovsek","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.ejps.2020.105643_bib0026","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1128\/AAC.00577-16","article-title":"Development and Evaluation of a Gentamicin Pharmacokinetic Model That Facilitates Opportunistic Gentamicin Therapeutic Drug Monitoring in Neonates and Infants","volume":"60","author":"Germovsek","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ejps.2020.105643_bib0027","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-199630050-00001","article-title":"A size standard for pharmacokinetics","volume":"30","author":"Holford","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0008","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.siny.2012.10.003","article-title":"Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration","volume":"18","author":"Jacqz-Aigrain","year":"2013","journal-title":"Semin Fetal Neonatal Med"},{"issue":"suppl_2","key":"10.1016\/j.ejps.2020.105643_bib0007","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1093\/cid\/cix663","article-title":"Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Kohli-Lynch","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ejps.2020.105643_bib0020","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/adc.56.12.900","article-title":"Measurement of the growth of the lateral ventricles in preterm infants with real-time ultrasound","volume":"56","author":"Levene","year":"1981","journal-title":"Arch Dis Child"},{"issue":"12","key":"10.1016\/j.ejps.2020.105643_bib0001","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00228-017-2313-4","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration","volume":"73","author":"Li","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ejps.2020.105643_bib0015","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/jps.24604","article-title":"Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients","volume":"104","author":"Li","year":"2015","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2017.11.005","article-title":"Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach","volume":"40","author":"Li","year":"2018","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11596390-000000000-00000","article-title":"Vancomycin:a review of population pharmacokinetic analyses","volume":"51","author":"Marsot","year":"2012","journal-title":"Clin Pharmacokinet"},{"issue":"22","key":"10.1016\/j.ejps.2020.105643_bib0002","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1097\/MD.0000000000000922","article-title":"An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases","volume":"94","author":"Matsunaga","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ejps.2020.105643_bib0032","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/2249-4847.123089","article-title":"Importance of Normal Values of CSF Parameters in Term Versus Preterm Neonates","volume":"2","author":"Majumdar","year":"2013","journal-title":"J Clin Neonatol"},{"issue":"8","key":"10.1016\/j.ejps.2020.105643_bib0014","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/AAC.43.8.1932","article-title":"Bactericidal Activity of Vancomycin in Cerebrospinal Fluid","volume":"43","author":"Nagl","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ejps.2020.105643_bib0013","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00381-017-3623-7","article-title":"Monitoring intraventricular vancomycin for ventriculostomy access device infection in preterm infants","volume":"34","author":"Parasuraman","year":"2018","journal-title":"Child's Nerv Syst"},{"issue":"3","key":"10.1016\/j.ejps.2020.105643_bib0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1227\/01.NEU.0000134289.04500.EE","article-title":"Risk of infection with prolonged ventricular catheterization","volume":"55","author":"Park","year":"2004","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.ejps.2020.105643_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00006454-198601000-00016","article-title":"Intraventricular vancomycin: observations of tolerance and pharmacokinetics in two infants with ventricular shunt infections","volume":"5","author":"Pau","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"5","key":"10.1016\/j.ejps.2020.105643_bib0028","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3171\/jns.2003.98.5.1040","article-title":"Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy","volume":"98","author":"Pfausler","year":"2003","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.ejps.2020.105643_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhin.2015.10.017","article-title":"Therapeutic drug monitoring of cerebrospinal fluid vancomycin concentration during intraventricular administration","volume":"92","author":"Popa","year":"2016","journal-title":"J Hosp Infect"},{"issue":"5","key":"10.1016\/j.ejps.2020.105643_bib0017","first-page":"331","article-title":"Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants","volume":"16","author":"Reiter","year":"1996","journal-title":"J Perinatol"},{"issue":"2","key":"10.1016\/j.ejps.2020.105643_bib0004","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/ajns.AJNS_150_16","article-title":"The organisms and factors affecting outcomes of external ventricular drainage catheter-related ventriculitis: A penang experience","volume":"13","author":"Sam","year":"2018","journal-title":"Asian J Neurosurg"},{"issue":"7","key":"10.1016\/j.ejps.2020.105643_bib0031","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3949\/ccjm.78a.10168","article-title":"Vancomycin: A 50-something-year-old antibiotic we still don't understand","volume":"78","author":"Schilling","year":"2011","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"10.1016\/j.ejps.2020.105643_bib0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/clpt.1994.120","article-title":"Population pharmacokinetics of vancomycin in neonates","volume":"56","author":"Seay","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ejps.2020.105643_bib0022","unstructured":"Thermo Scientific. QMS \u00ae Vancomycin (VANCO). 2015:1-3. https:\/\/tools.thermofisher.com\/content\/sfs\/manuals\/0155171-QMS-Vancomycin-Assay-EN.pdf."},{"key":"10.1016\/j.ejps.2020.105643_bib0024","year":"2014","journal-title":"Intravenous Vancomycin"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720304310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720304310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:56:13Z","timestamp":1778558173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720304310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":34,"alternative-id":["S0928098720304310"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105643","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105643"}}